SARS-CoV-2 T-cell response in COVID-19 convalescent patients with and without lung sequelae

A specific T-cell response persists in the majority of COVID-19 patients 6 months after hospital discharge. This response is more prominent in those who required critical care during the acute COVID-19 episode but is reduced in patients with lung sequelae. https://bit.ly/3fBuVA4

Detalles Bibliográficos
Autores principales: Cruz, Tamara, Mendoza, Núria, Perea, Lídia, Albacar, Núria, Gonzalez, Azucena, Hernandez-Gonzalez, Fernanda, Juan, Manel, Agustí, Alvar, Sellares, Jacobo, Sibila, Oriol, Faner, Rosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845009/
https://www.ncbi.nlm.nih.gov/pubmed/35261913
http://dx.doi.org/10.1183/23120541.00706-2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845009/
https://www.ncbi.nlm.nih.gov/pubmed/35261913
http://dx.doi.org/10.1183/23120541.00706-2021

Ejemplares similares